C2orf48 Inhibitors

PI3K and mTOR inhibitors, such as Wortmannin and Temsirolimus, would interfere with critical signaling related to cell growth and survival, which can have downstream effects on proteins associated with these pathways. Similarly, inhibitors of MAPK/ERK or JAK/STAT signaling, like PD98059 and Tofacitinib, could impede the transmission of growth or inflammatory signals, affecting the function of C2orf48 if it is involved in these signaling cascades.

Other compounds, such as histone deacetylase (HDAC) inhibitors like Trichostatin A, could affect the expression levels of C2orf48 by altering the acetylation state of histones associated with its gene. Proteasome inhibitors, such as Bortezomib, would prevent the degradation of proteins, potentially leading to an accumulation of proteins that regulate or interact with C2orf48, thereby affecting its activity. Inhibitors like GSK3β, NF-κB, and TGF-β receptor inhibitors would alter signaling pathways that regulate cell differentiation and immune responses. If C2orf48 has a role in these pathways, such compounds would influence its activity indirectly. Calcium channel blockers and autophagy inhibitors would affect cellular homeostasis and metabolism, with potential repercussions on C2orf48 functions.